Sermorelin
C149H246N44O42S3357.93 g/mol
$46.00
$9.20 per mg
GHRH(1-29)-NH₂, the shortest fully active fragment of growth hormone–releasing hormone.
Buy more, save more
Applies to any mix of sizes of this compound. Discount shows in your cart.
- Batch RP-SER-2610, lab report sent on request
- Sealed vial, discreet unbranded packaging
- Order now and it ships on Monday
For in-vitro laboratory research only. Not for human or veterinary use.
Structure
- Hydrophobic
- Polar
- Acidic
- Basic
- Modified / non-standard
Specifications
| Also known as | GRF (1-29) NH₂, GHRH (1-29) |
|---|---|
| Sequence | YADAIFTNSYRKVLGQLSARKLLQDIMSR C-terminal amide |
| Molecular formula | C149H246N44O42S |
| Molecular weight | 3357.93 g/mol |
| CAS number | 86168-78-7 |
| Purity specification | ≥98.0% (HPLC) |
| Form | Lyophilized powder, 3 mL glass vial |
| Storage | −20 °C, sealed, protected from light |
Stock solution calculator
Work out the concentration of an in-vitro stock solution from the vial contents and the solvent volume, using this compound’s molecular weight.
- Mass concentration
- –
- Molar concentration
- –
- Amount of substance
- –
Uses MW 3357.93 g/mol and gross fill weight. For quantitative work, correct for net peptide content.
Batch history
Every batch we have released for this compound, with the report for each. Older reports stay available so you can compare lots.
-
RP-SER-2610 Shipping now
Request report
Research overview
Sermorelin is GHRH(1-29)-NH₂, the N-terminal 29 residues of growth hormone–releasing hormone. This fragment retains the full biological activity of the 44-residue native hormone at the GHRH receptor.
It has a long history as a research tool for studying pituitary GHRH-receptor signalling and somatotroph function, and serves as the reference sequence for later analogues such as modified GRF (1-29).
Related products
-
GH Secretagogues
Ipamorelin
5 mg10 mg
From $44.00 Choose size This product has multiple variants. The options may be chosen on the product page
